Tower Research Capital LLC (TRC) - APPLIED MOLECULAR TRANS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of APPLIED MOLECULAR TRANS INC
ValueSharesWeighting
Q3 2023$574
-39.6%
3,654
-0.8%
0.00%
Q2 2023$950
+94900.0%
3,683
-6.5%
0.00%
Q1 2023$1
-80.0%
3,939
-63.7%
0.00%
Q4 2022$5
-99.9%
10,854
+143.4%
0.00%
Q3 2022$4,000
-55.6%
4,459
+39.2%
0.00%
Q2 2022$9,000
-10.0%
3,203
+130.4%
0.00%
Q1 2022$10,000
-77.8%
1,390
-56.7%
0.00%
-100.0%
Q4 2021$45,000
+350.0%
3,213
+691.4%
0.00%
Q3 2021$10,000
-86.3%
406
-74.3%
0.00%
-100.0%
Q2 2021$73,000
+78.0%
1,581
+68.4%
0.00%
+100.0%
Q1 2021$41,000
-29.3%
939
-50.4%
0.00%
-50.0%
Q4 2020$58,000
-10.8%
1,893
-6.9%
0.00%
+100.0%
Q3 2020$65,0002,0340.00%
Other shareholders
APPLIED MOLECULAR TRANS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Founders Fund V Management, LLC 3,611,615$165,195,00056.39%
EPIQ Capital Group, LLC 8,764,720$400,899,00041.88%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 175,000$8,004,0000.73%
Burleson & Company, LLC 106,277$4,861,0000.71%
Virtus ETF Advisers LLC 4,565$209,0000.09%
Maven Securities LTD 34,191$1,569,0000.06%
Woodline Partners LP 50,600$2,314,0000.04%
Capital Research Global Investors 3,930,356$179,774,0000.04%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 40,500$1,852,0000.03%
Capital World Investors 4,197,918$192,013,0000.03%
View complete list of APPLIED MOLECULAR TRANS INC shareholders